aa2018-mobile-app-iconsclinical_cymposium_300x300
Description
Head and neck cancers in the United States account for about 3% of all cancers with close to 60,000 new cases developing annually. With a changing demographic, the annual incidence is increasing. Successful treatment with surgery, radiation and chemotherapy accounts for long term survivorship rates close to 70%. It also results in short and long term survivorship issues and with an ageing population, these patients can have life-long and progressive disabilities. We will review the more common short and long term complications of head and neck cancer treatment. Innovative techniques for facial reanimation will be presented. Assistive technologies in voice restoration will be discussed. Novel approaches to prevention and management of post treatment facial lymphedema, head and neck myofascial fibrosis and dropped head syndrome will be detailed. Long term survivorship issues will be reviewed including nutritional status, lifestyle management and integration of aerobic and strength training for overall health and function
Tags